This process was inhibited by treatment with the PI3 kinase and actin polymerization inhibitors wortmannin and latrunculin A, respectively, which suggested that the acquisition of CD4 and CD45 by cancer cells occurs via trogocytosis. Here, CD4 is linked to cancer.